David B. Bylund

David B. Bylund's AcademicInfluence.com Rankings

David B. Bylund

Medical

#2137

World Rank

#2538

Historical Rank

Pharmacology

#221

World Rank

#261

Historical Rank

medical Degrees

Download Badge

Medical

David B. Bylund's Degrees

PhD Pharmacology University of California, Irvine
Bachelors Pharmacy University of California, San Francisco

Why Is David B. Bylund Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David B. Bylund's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International Union of Pharmacology nomenclature of adrenoceptors. (1994) (1237)
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. (1995) (728)
Beta adrenergic receptor binding in membrane preparations from mammalian brain. (1976) (548)
Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence converg (1988) (342)
Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. (1988) (315)
Subtypes of α1‐ and α2‐adrenergic receptors (1992) (297)
Heterogeneity of alpha-2 adrenergic receptors (1985) (288)
Neurotransmitter receptors in frontal cortex of schizophrenics. (1979) (256)
Characterization of α1-and α2-Adrenergic Receptors (1983) (220)
Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. (1992) (213)
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. (2008) (192)
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. (2000) (189)
Huntington's chorea. Changes in neurotransmitter receptors in the brain. (1976) (187)
Substrate specificity of the cyclic AMP-dependent protein kinase. (1975) (160)
(+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. (1978) (157)
Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland. (1991) (142)
Alterations of brain neurotransmitter receptor binding in Huntington's chorea (1976) (135)
Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. (1991) (133)
Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. (2007) (126)
Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. (1988) (112)
Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. (1988) (107)
Pharmacological characterizations of adrenergic receptors in human adipocytes. (1981) (106)
Childhood and adolescent depression: Why do children and adults respond differently to antidepressant drugs? (2007) (105)
Subtypes of alpha-1 and alpha-2 adrenergic receptors (1992) (102)
Radioligand binding methods: practical guide and tips (1993) (102)
Neurotransmitter receptor binding: regional distribution in human brain (1977) (99)
Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. (1986) (94)
Effect of denaturation on the susceptibility of proteins to enzymic phosphorylation. (1975) (92)
Decomposition of phosphoserine and phosphothreonine during acid hydrolysis. (1976) (91)
Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. (1994) (89)
A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29 (1986) (85)
Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. (1991) (84)
α2‐Adrenergic receptor binding in human platelets: Alterations during the menstrual cycle (1983) (81)
Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. (1989) (80)
In Vivo Gene Modification Elucidates Subtype-Specific Functions of a 2-Adrenergic Receptors 1 (2000) (73)
α-2A Is the Predominant α-2 Adrenergic Receptor Subtype in Human Spinal Cord (1992) (71)
Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. (1983) (65)
Vascular α-adrenoceptors: from the gene to the human (1995) (63)
Pharmacological Characteristics of Alpha‐2 Adrenergic Receptor Subtypes (1995) (63)
Development of the norepinephrine transporter in the rat CNS (2005) (63)
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. (1994) (62)
Forskolin does not activate sperm adenylate cyclase. (1983) (62)
Radioligand binding methods: practical guide and tips. (1994) (62)
α2-Adrenergic receptors appear in rat salivary glands after reserpine treatment (1980) (58)
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. (1985) (57)
Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung. (1982) (56)
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression (2008) (54)
Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line. (1994) (53)
Age-related parallel decline in beta-adrenergic receptors, adenylate cyclase and phosphodiesterase activity in rat erythrocyte membranes. (1977) (53)
Pharmacologic principles for combination therapy. (2005) (52)
Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates. (1999) (50)
The amino acid sequences of the phosphorylated sites in troponin‐I from rabbit skeletal muscle (1974) (49)
Differential localization of α 2-adrenergic receptor subtypes in brain (1992) (49)
The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment (2008) (48)
Independent variation of beta-adrenergic receptor binding and catecholamine-stimulated adenylate cyclase activity in rat erythrocytes. (1976) (48)
Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. (1981) (46)
Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity (1986) (44)
Platelet MAO in children with attention deficit disorder and hyperactivity: a pilot study. (1982) (43)
Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. (1997) (42)
Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. (1992) (41)
Alpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytes. (1982) (40)
Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. (1989) (40)
Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H]nitrendipine binding and calcium and sodium fluxes in brain. (1985) (40)
Alpha-2 adrenergic receptor functional coupling to G proteins in rat brain during postnatal development. (1999) (39)
Low Density Lipoprotein Receptor Related Protein (2008) (38)
Alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production. (1987) (38)
Radioligand binding methods for membrane preparations and intact cells. (2011) (37)
Studies on desensitization of adrenergic receptors of human adipocytes. (1982) (37)
Differential Effects of the Tricyclic Antidepressant Desipramine on the Density of Adrenergic Receptors in Juvenile and Adult Rats (2007) (36)
Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex. (1985) (35)
Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes. (1996) (35)
Differential down-regulation of alpha-2 adrenergic receptor subtypes. (1998) (35)
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptors. (2007) (33)
Characterization and possible mechanisms of alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. (1988) (31)
Beta adrenergic receptor labeling in intact animals with 125I-hydroxybenzylpindolol. (1977) (31)
Agonist-stimulated [35S]GTPγS autoradiography : optimization for high sensitivity (2001) (30)
Effects of chronic reserpine administration on beta adrenergic receptors, adenylate cyclase and phosphodiesterase of the rat submandibular gland. (1981) (30)
Ascorbic acid inhibition of alpha-adrenergic receptor binding. (1986) (29)
Desensitization of the alpha-2 adrenergic receptor in HT29 and opossum kidney cell lines. (1990) (29)
Molecular determinants of the alpha-2D adrenergic receptor subtype. (1993) (28)
Norepinephrine and Dopamine Metabolites and Educational Variables in Boys With Attention Deficit Disorder and Hyperactivity (1987) (28)
Radioligand saturation binding experiments over large concentration ranges. (2000) (28)
A simple, sensitive and specific radioreceptor assay for beta-adrenergic antagonist drugs. (1978) (28)
cAMP-dependent reduction in membrane fluxes during relaxation of arterial smooth muscle. (1984) (27)
Graphic presentation and analysis of inhibition data from ligand-binding experiments. (1986) (26)
Expression of alpha 2-adrenergic receptor genes in rat tissues. (1994) (26)
Characterization of the alpha-1 adrenergic receptors in the thoracic aorta of control and aldosterone hypertensive rats: correlation of radioligand binding with potassium efflux and contraction. (1987) (26)
Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists. (1999) (26)
β-Adrenergic receptor binding in guinea pig cerebral cortex (1978) (25)
Characterization of alpha 1- and alpha 2-adrenergic receptors. (1983) (24)
Platelet monoamine oxidase (MAO) activity: Personality, substance use, and the stress-response-dampening effect of alcohol. (1994) (23)
Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies. (1998) (23)
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-EC. (1984) (23)
Inverse agonism at α2-adrenoceptors in native tissue (2000) (23)
Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. (2007) (23)
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century. (2014) (23)
Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies (2007) (23)
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats (2009) (22)
Alpha-1 adrenergic receptor binding in aortas from rat and dog: comparison of [3H]prazosin and beta-iodo-[125I]-4-hydroxyphenyl-ethyl-aminomethyl-tetralone. (1987) (22)
Oxymetazoline inhibits adenylate cyclase by activation of serotonin-1 receptors in the OK cell, an established renal epithelial cell line. (1988) (22)
Psychoeducational and impulsivity correlates of platelet MAO in normal children (1984) (21)
Analysis of brain adrenergic receptors in dopamine-β-hydroxylase knockout mice (2006) (21)
Identification of α2‐Adrenergic Receptors in Chicken Pineal Gland Using [3H]Rauwolscine (1988) (21)
α 2-agonist binding sites in brain: [125I]Para-iodoclonidine versus [3H]para-aminoclonidine (1993) (20)
Differential effects of neonatal norepinephrine lesions on immediate early gene expression in developing and adult rat brain (2008) (20)
α2-Adrenoceptor-stimulated GTPγS binding in rat brain: an autoradiographic study (2000) (20)
alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. (1983) (19)
Vascular alpha-adrenoceptors: from the gene to the human. (1995) (19)
Alpha-2 adrenergic receptors in the bovine retina. Presence of only the alpha-2D subtype. (1995) (18)
Desensitization and down-regulation of the 5-hydroxytryptamine1B receptor in the opossum kidney cell line. (1992) (18)
Down-regulation of α2-adrenoceptor subtypes (1993) (18)
Molecular modelling of subtypes (α2A, α2B and α2C) of α2-adrenoceptors: A comparative study (2009) (17)
The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor. (1994) (17)
Characterization of adrenergic receptor binding in rat lung: physiological regulation. (1983) (17)
Characterization of beta-adrenergic receptors in fresh and primary cultured bovine corneal endothelium. (1985) (17)
Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice. (2006) (16)
Platelet MAO activity and personality variations in normals (1989) (16)
Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations. (1987) (16)
Pharmacological evidence for alpha 2c and alpha 2d adrenergic receptor subtypes (1991) (16)
alpha-2 Adrenergic Receptors (1988) (16)
Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine. (1982) (15)
α2A- and α2C-Adrenoceptor subtypes are differentially down-regulated by norepinephrine (1991) (15)
Biochemistry and Pharmacology of the alpha-1 Adrenergic Receptor (1987) (14)
Comparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytes. (1987) (14)
Effects of alpha 2-adrenergic agonist preincubation on subsequent forskolin-stimulated adenylate cyclase activity and [3H]forskolin binding in membranes from HT29 cells. (1990) (13)
Down-regulation of the alpha-2C adrenergic receptor: involvement of a serine/threonine motif in the third cytoplasmic loop (2002) (13)
Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development (2011) (13)
Quantitative versus qualitative data: the numerical dimensions of drug action. (2014) (12)
Regulation of central adrenergic receptors. (1979) (11)
Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity. (2001) (11)
15-Deoxy-delta-12, 14 PGJ-2 (2008) (11)
Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates. (1997) (11)
Characteristics of β-adrenergic receptors in bovine corneal epithelium: Comparison of fresh tissue and cultured cells (1984) (11)
Differential localization of alpha 2-adrenergic receptor subtypes in brain. (1992) (11)
Comparison of adrenergic receptor binding in blood cells from alcoholics and controls. (1984) (10)
Inverse agonism at alpha(2)-adrenoceptors in native tissue. (2000) (9)
THE PREDOMINANT ALPHA-2 ADRENERGIC RECEPTOR SUBTYPE IN HUMAN SPINAL CORD IS ALPHA-2A (1992) (9)
The Dose—Response Model for Dioxin (1998) (9)
Platelet alpha2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder (1994) (9)
Glucagon-like Peptide-1 (7-36) Amide (2008) (8)
p-Azidoclonidine: a photoaffinity label for the α2-adrenoceptor (1985) (8)
X Linked Inhibitor of Apoptosis (2008) (8)
Adrenoceptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (8)
Factors affecting urinary excretion of 3-methoxy-4-hydroxyphenylglycol in children and its clinical significance. (1984) (8)
The Chronically Reserpinized Rat as a Model for Cystic Fibrosis: Alterations in the Mucus-Secreting Sublingual Gland (1983) (8)
Ouabain. (1937) (8)
Synthesis and biodistribution of the alpha 2-adrenergic receptor antagonist (11C)WY26703. Use as a radioligand for positron emission tomography. (1992) (8)
Characterization of α-adrenergic receptors in rat lung membranes: presence of α1 but not α2 receptors (1981) (8)
Interferon Inducible Protein 10 (2008) (7)
Platelet alpha2-adrenergic receptor binding to 3H-yohimbine and personality variations in normals (1990) (6)
Alpha(2)-adrenoceptor-stimulated GTP gamma S binding in rat brain: an autoradiographic study. (2000) (6)
Adrenergic receptor genes (2002) (6)
Platelet alpha 2-adrenergic receptor binding and the effects of d-amphetamine in boys with attention deficit hyperactivity disorder. (1994) (6)
Soybean Trypsin Inhibitor (2008) (6)
Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines. (2005) (6)
Glucagon-like Peptide-1 (7-37) (2008) (6)
Radioligand-binding methods for membrane preparations and intact cells. (2004) (5)
A robust GTP-induced shift in α2-adrenoceptor agonist affinity in tissue sections from rat brain (2001) (5)
Characteristics of beta-adrenergic receptors in bovine corneal epithelium: comparison of fresh tissue and cultured cells. (1984) (4)
Norepinephrine: Adrenergic Receptors (2009) (4)
Construction of libraries for isolation of adrenergic receptor genes. (2000) (4)
Synthesis and α-adrenergic and I1-imidazoline activity of 3-phenylpiperidines dimethyl-substituted on the phenyl ring (1998) (4)
Characterization of Adrenoceptors (2007) (4)
Receptor Binding Assays and Drug Discovery. (2018) (3)
Brain Norepinephrine: Receptors for norepinephrine and signal transduction pathways (2007) (3)
Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration (2008) (3)
Adrenoceptors in GtoPdb v.2021.3 (2021) (3)
Characterization of autonomic receptors in the rat sublingual gland by biochemical and radioligand assays (1982) (3)
Selecting selectivities and the neuropharmacology of antidepressant drug action (2007) (2)
Down-regulation of alpha 2-adrenoceptor subtypes. (1993) (2)
2,4-Dinitrophenol (2008) (2)
Beta-2 Adrenoceptor (2008) (2)
Alpha-1 Adrenoceptors* (2008) (2)
Reduced Nicotinamide Adenine Dinucleotide Phosphate (2008) (2)
Beta-3 Adrenoceptor* (2007) (2)
Insulin-Like Growth Factor-2 (2008) (2)
Reduced Nicotinamide Adenine Dinucleotide (2008) (2)
Membrane transport in vascular smooth muscle and its relation to normal and altered excitation during hypertension (2006) (1)
p-Azidoclonidine: a photoaffinity label for the alpha 2-adrenoceptor. (1985) (1)
7-Transmembrane Receptors (2008) (1)
Adrenergic receptor alpha 2a (2009) (1)
Corn Trypsin Inhibitor (2008) (1)
The binding of rauwolscine and RX821002 to the alpha-2-adrenergic receptor subtypes is differentially altered by buffers (1996) (1)
Coagulation Factor IX-X-Binding Protein (2008) (1)
Pharmacologic specificity of alpha-2 adrenergic receptor subtypes (1986) (1)
Alpha 2A- and alpha 2C-adrenoceptor subtypes are differentially down-regulated by norepinephrine. (1991) (1)
Alpha 2 Antiplasmin (2008) (1)
Alpha-2 Adrenoceptors* (2008) (1)
Alpha-Conotoxin MII (2008) (1)
Beta-1 Adrenoceptor (2008) (1)
Prediction of centrifugation times for equilibrium and velocity sedimentation on various gradients. (1974) (1)
Alpha-2A Adrenoceptor (2008) (1)
Isolation of adrenergic receptor genes. (2000) (1)
Receptor Types and Subtypes (2014) (1)
Altered coupling between aortic adrenergic-receptors and inositol phosphate accumulation in aldosterone hypertension (1986) (1)
Analyses of adrenergic receptor sequences. (2000) (0)
Alpha-2 Adrenergic Receptor Functional Coupling to G Proteins in Rat Brain During Postnatal Development 1 (1999) (0)
Azepanone SB-468430 (2008) (0)
Coagulation Factor XIa as an Agent (2008) (0)
Guanidinoethyl-Mercaptosuccinic Acid (2008) (0)
GTP gamma S (2014) (0)
Ro 41-1049 (2008) (0)
Met-Chemokine beta7 (2008) (0)
15-Deoxy-15, 15-Ethylenedioxy-16-Phenoxy-Omega-Tetranor PGF-2alpha (2008) (0)
Dodecyl Octaoxyethylene Ether (2008) (0)
1,1-Dimethyl-4-Acetylpiperazinium Iodide (2008) (0)
Alpha-1A Adrenoceptor* (2008) (0)
Immediate early gene response to antidepressants acting on the noradrenergic system differs between juvenile and adult rats (0)
Pharmacological characterization of the receptors mediating vasoactive intestinal peptide-induced vasodilation in rat aorta (1986) (0)
Potato Carboxypeptidase Inhibitor (2008) (0)
CAMKII aa281-302ALA286 (2008) (0)
AcPhe-[OPro-D-ChaTrpArg] (2008) (0)
9-(Cyclopentenyl)-Adenine (2008) (0)
Alpha-adrenergic receptors (1996) (0)
NNC 92-1687 2-(Benzimidazol-2-ylthio)- 1-(3,4-Dihydroxyphenyl-1-Ethan one (2008) (0)
1-Deoxo PGF-2alpha (2008) (0)
Effect of alpha‐2C adrenergic receptor Del322‐325 polymorphism on cyclic AMP production in HEK293 cells (2007) (0)
Characterization of alpha-adrenergic receptors in rat lung membranes: presence of alpha 1 but not alpha 2 receptors. (1981) (0)
Alpha-1D Adrenoceptor* (2008) (0)
Coagulation Factor X as an Agent (2008) (0)
Amyloid Precursor Protein (2008) (0)
6-Tridecylresorcyclic Acid (2008) (0)
Phorbol 13 Acetate 12 Myristate (2008) (0)
Synthesis and binding to beta-adrenergic receptors of p-aminobenzyl analogues of practolol and atenolol. (1992) (0)
BB1 Bombesin Receptor (2007) (0)
Inhibition of cyclic AMP production is not reduced in HEK293 cells expressing the alpha‐2C adrenergic receptor Del322–325 polymorphism (2008) (0)
Alpha Adrenoceptor Agents (2008) (0)
CAMKII aa290-309 (2008) (0)
Alpha-2B Adrenoceptor* (2008) (0)
The forced‐swim test in juvenile rats: A model to screen antidepressant efficacy for childhood and adolescent depression (2008) (0)
L-Cysteinesulphinic Acid (2008) (0)
16-Phenoxy-Omega-Tetranor PGF-2alpha (2008) (0)
Arg10 NH 2 (2008) (0)
ROLE OF THE THIRD INTRACELLULAR LOOP OF THE ALPHA-2 ADRENERGIC RECEPTOR INREGULATING RECEPTOR DENSITY (1998) (0)
Amino-oxypentane (AOP)-RANTES (2008) (0)
SDZ 64-412 (2008) (0)
11-Deoxy PGE-1 (2008) (0)
O-Methyl-O-(p-Nitrophenyl) n-Undecylphosphonate (2008) (0)
Changes in GRK3/2 Levels in Brain Regions of Learned Helpless and Non‐Helpless Rats (2008) (0)
2-(3-Fluorophenyl)histamine (2008) (0)
Neurotransmitter receptors: molecular pharmacology of neurotransmitter receptors. (1983) (0)
Des-AA1,5[125ITyr2, D-Trp8, IAmp9]-SRIF (2008) (0)
Filgrastim (G-CSF) (2007) (0)
19R-19-Hydroxy PGE-2 (2008) (0)
Pharmacological Regulation of Receptor-Mediated Indoleamine Metabolism in the Mammalian Pineal Glands (1991) (0)
15-Oxo PGF-2alpha (2008) (0)
35Depression, Bipolar Syndromes, and Schizophrenia (2008) (0)
(6bS,7R,8S)-7-methoxy-4,8,9-trihydroxy-1,6b,7,8-tetrahydro-2H-benzo(j)fluoranthen-3-one(1) (2008) (0)
7-Benzylidine-7-Dehydronaltrexone (2008) (0)
Alpha-Conotoxin AuIB (2008) (0)
Lipophilic Alpha-Keto Amide (2008) (0)
D-Helical Peptide 294 (2008) (0)
2-(Benzothiazolethio) Acetamide Derivative-1a (2008) (0)
Alpha 2 Macroglobulin (2008) (0)
p-(4-Hydroxybenzoyl)Phenylalanine (2008) (0)
9-(4-Hydroxybuthyl)-N2-Phenylguanine (2008) (0)
Today's research, tomorrow's health: focus on pharmacogenomics. (2007) (0)
Delta-12 PGJ-2 (2008) (0)
How Physical and Chemical Information Predicts the Action of Molecules: A Historical Overview (2018) (0)
Alpha‐2 Adrenergic Receptor Homology Models using Rhodopsin or Beta‐2 Adrenergic Receptor Templates (2009) (0)
Protein C Inhibitor (2008) (0)
15R PGF-2alpha (2007) (0)
Identification of β adrenergic receptor binding in intact animals (1976) (0)
Azepanone 20, SB-357114 (2008) (0)
Lysergic Acid Diethylamide (2008) (0)
Major Depression, Bipolar Syndromes, and Schizophrenia (2008) (0)
Cyclo19,31[D-Cys19]-uPA19-31 (2008) (0)
RNA Aptamer 9.3 (2008) (0)
Des-His 1-[Glu9]Glucagon Amide (2008) (0)
Dodecyldithio-5-(2-Nitrobenzoic Acid) (2008) (0)
9-(Tetrahydrofuryl)-Adenine (2008) (0)
Morpholine-4-Carboxylic Acid [1S-(2-Benzyloxy-1R-Cyano-Ethylcarbamoyl)-3-Methylbutyl]amide (2008) (0)
Differential alpha‐2 adrenergic functional response in juvenile versus adult rats treated with the tricyclic antidepressant desipramine (0)
(Z-LL)-2-Ketone (2008) (0)
15R-17-Phenyl-Omega-Trinor PGF-2alpha (2008) (0)
Z-Phe-Cys(SBzl)-CH 2 O-CO-2,6-(CF3)2-Ph (2007) (0)
Echis Carinatus Leucogaster Venom Coagulation Factor IX-X-Binding Protein (2008) (0)
Beta-CH-TRH (2008) (0)
NIGMS-sponsored integrative and organ systems pharmacology: synopsis of the 2005 experience/anticipation of the 2006 short courses. (2005) (0)
Leu-CH 3 (2008) (0)
Ro 32-0432 (2008) (0)
Alpha Adrenergic Receptor Agents (2014) (0)
TYR 0 sauvagine (2008) (0)
Plant Serine Protease Inhibitor (2008) (0)
Time of Day and Length of Antidepressant Drug Administration Influence Brain-Derived Neurotrophic Factor and TrkB Levels in Rat Brain (2009) (0)
Alpha-1B Adrenoceptor (2008) (0)
The forced‐swim test and learned helplessness paradigm in juvenile rats model the lack of efficacy of tricyclic antidepressants in childhood and adolescent depression (2007) (0)
4,6-O-Ethylidene Glucose (2008) (0)
Difluoro Ketone Peptidomimetic (2008) (0)
4 Methylglutamic Acid (2008) (0)
UNIT 1.5 Characterization of Adrenoceptors (2001) (0)
1-Deoxo-1-O-Methyl PGF-2alpha (2008) (0)
Mathematical theory of competitive binding assays: an exact and practical model. (1997) (0)
2-Amino-3-Guanidinopropionate (2008) (0)
COMPARISON OF 3H-DIHYDROALPRENOLOL BINDING TO PUTATIVE β1 AND β2-ADRENERGIC RECEPTORS SITES IN THE CNS OF SEVERAL MAMMALIAN SPECIES (1979) (0)
16, 16-Dimethyl PGE-2 (2008) (0)
L-803,087 (2008) (0)
Differential regulation of BDNF in juvenile rats after escitalopram and desipramine treatment (2007) (0)
Complement Component C1s Inhibitor (2008) (0)
2-[3 -(Trifluoromethyl) phenyl] histamine (2008) (0)
L-Homocysteinesulphinic Acid (2008) (0)
[(CH2NH)4,5]secretin (2008) (0)
Phage-Derived Hexapeptide (2008) (0)
Alpha-2C Adrenoceptor (2008) (0)
Synthesis and α2-Adrenergic Activities of Imidazole and Imidazolidine Analogues: in vitro and in vivo Selectivity. (1995) (0)
19R-19-Hydroxy PGF-2alpha (2008) (0)
Neurotransmitter Receptors: Molecular Pharmacology of Neurotransmitter Receptors . Tomio Segawa, Henry I. Yamamura, and Kinya Kuriyama, Eds. Raven, New York, 1983. xvi. 304 pp., illus. $44. Advances in Biochemical Psychopharmacology, vol. 36. (1983) (0)
Z-Leu-Leu-Tyr-CHN 2 (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David B. Bylund?

David B. Bylund is affiliated with the following schools:

University of Nebraska Medical Center